We are proud to present an overview of the Canadian Cancer Clinical Trials Network’s (3CTN) accomplishments and progress made throughout the 2025-2026 fiscal year. Read about the Impact of 3CTN’s Academic Clinical Trial Portfolio, Advancing Equity in Cancer Clinical Trials, the Incoming Chair of the Patient Representative Advisory Sub-Committee, the 3CTN Travel and Education Grant, EDGE Working Groups, High-Priority Trials and Regional Performance Highlights.
